Abstract
Colposcopic inspection of the vagina is a routine component of the safety assessment of intravaginal products. However, colposcopic findings occur frequently in healthy women, raising questions about their relevance to intravaginal product safety. Practical disadvantages limit the utility of colposcopy for evaluating menstrual tampons, among them the presence of background microtrauma, the inability to assess effects during menstruation, and, importantly, the question of whether post-hoc assessments are sufficiently sensitive to detect small inflammatory changes. The Behind-the-knee (BTK) test is an alternative for evaluating inflammatory and tissue dryness effects of physical articles by their repeated application to the popliteal fossa under an elastic bandage. It enables concurrent parallel comparisons of experimental and control articles over time and substantially increases the sensitivity of detecting small changes in tissue inflammation. With this protocol, uncompressed experimental and control tampons yielded comparable relative and absolute erythema scores (after overnight recovery) as did colposcopic assessment of the lower genital tract 3 to 48 hours after menstrual use. Scoring erythema in the BTK test immediately after product removal increased the level of visually discernible inflammation 6-fold. In a study of commercial menstrual pads, subclinical inflammation visualized with cross-polarized light correlated with the frequency of subjective reports of discomfort during the test and discriminated the relative tolerability of the two products determined by market surveillance, providing added confidence in the predictive value of the test. We believe the BTK test to be a valuable alternative to colposcopy for assessing inflammation and dryness associated with menstrual tampons.
Highlights
Colposcopy was first described in 1925 as a screening tool for cervical cancer but was later supplanted for primary screening by the Papanicolaou test (Pap smear)
We believe the BTK test to be a valuable alternative to colposcopy for assessing inflammation and dryness associated with menstrual tampons
Erythema and petechiae of the cervix and vagina were found at baseline colposcopic evaluation of about one-third of women entering product use studies [3] and many superficial alterations were observed over four to six months of colposcopic inspection of the vaginal epithelium of healthy women [4]
Summary
Colposcopy (colpo: vagina; scope: to look) was first described in 1925 as a screening tool for cervical cancer but was later supplanted for primary screening by the Papanicolaou test (Pap smear). On the most fundamental level, we do not fully understand the natural history and clinical significance of minor alterations to the vaginal epithelium, many of which occur absent product use. Erythema and petechiae of the cervix and vagina were found at baseline colposcopic evaluation of about one-third of women entering product use studies [3] and many superficial alterations were observed over four to six months of colposcopic inspection of the vaginal epithelium of healthy women [4]. Advancing age [3], tampon use [4], smoking [4], and intercourse in the prior 72 hours [4,5] contribute to vaginal microtrauma; these and other likely confounding factors (the menstrual cycle, exogenous hormones, barrier contraceptive use) create background “noise” of uncertain clinical significance [2,6] that may make it difficult to assess the impact of changes in products designed to be minimally irritating, such as menstrual tampons
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.